[Federal Register: October 2, 2003 (Volume 68, Number 191)]
[Notices]               
[Page 56852]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02oc03-85]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 7, 2003, and published in the Federal Register 
on May 29, 2003 (68 FR 32089), Organix, Inc., 240 Salem Street, Woburn, 
Massachusetts 01810, made application by renewal to the Drug 
Enforcement Administration to be registered as a bulk manufacturer of 
the basic class of Cocaine (9041), a Schedule II controlled substance.
    The firm plans to manufacture small quantities of a cocaine 
derivative for distribution for research purposes.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Organix, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Organix, Inc. to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed is granted.

    Dated: August 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-24983 Filed 10-1-03; 8:45 am]

BILLING CODE 4410-09-M